Clinical Trials Directory

Trials / Sponsors / Pharvaris Netherlands B.V.

Pharvaris Netherlands B.V.

Industry · 7 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Phase 32025-10-16
RecruitingLong-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema A
Hereditary Angioedema (HAE)
Phase 32025-02-01
Active Not RecruitingStudy of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents
Hereditary Angioedema (HAE)
Phase 32024-12-01
CompletedStudy of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adul
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II
Phase 32024-02-26
Enrolling By InvitationExtension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angio
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II
Phase 2 / Phase 32022-12-28
CompletedDose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary A
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II
Phase 22022-04-19
CompletedDose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary An
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II
Phase 22021-02-03